Fundraising Fox

Modulari-T

YC W23

Montreal, CA · Founded 2021 · 4 employees · 3 known investors

Modulari-T develops proprietary cell therapy technologies, including the MARC receptor and MoVe platform, based on primary research into immune system architecture. The company serves the cell therapy and immunotherapy market.

Also known as Modulari-T Biosciences

Founders & leadership· Y Combinator alumni (W23)

Modulari-T was founded in 2021 by David White and Stephanie Mok.

DWDavid White
David WhiteinCo-founder · President and CSODavid White completed a PhD where he researched protein receptors and their mechanisms for altering cellular behavior, which led him to found Modulari-T.
SMStephanie Mok
Stephanie MokinCo-Founder & COOStephanie Mok is co-founder and COO at Modulari-T, where she applies expertise in synthetic biology, 3D cell culture systems, and biomaterials. She holds a PhD in chemical engineering.

Investors · 3

Competitors · 2

by search overlap

Companies competing with Modulari-T for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Modulari-T do?
Modulari-T develops proprietary cell therapy technologies, including the MARC receptor and MoVe platform, based on primary research into immune system architecture. The company serves the cell therapy and immunotherapy market.
Who founded Modulari-T?
Modulari-T was founded by David White, Stephanie Mok in 2021.
Who are Modulari-T's investors?
Modulari-T's investors include Metaplanet, Y Combinator, BoxOne Ventures.
Where is Modulari-T headquartered?
Modulari-T is headquartered in Montreal, CA.